Three Longevity Global members pitched their companies:
1. Ravi Kota, CEO of AITCare
AITCare is pioneering the future of elder care. With cutting-edge technology and a compassionate approach, we empower care facilities, caregivers, and families to provide exceptional support to older adults. Our AI-driven platform, AITCare-II, detects early-stage symptoms of memory loss and offers a holistic ecosystem for real-time monitoring and personalized engagement. We're gaining industry recognition with four paid customers, six contracts, and eleven Letters of Intent. Join us in reshaping senior care for a brighter, more compassionate future.
2. Kris Barnes, CEO of LentoBio
Developing small molecule therapeutics targeting aging damage, with focus on presbyopia.
Presbyopia is an aging disease which happens to all people around age 40-45, making it among the earliest onset aging diseases with a market value estimated at $9-18B annually. Lento Bio is developing small molecule eyedrops to treat presbyopia by improving the flexibility of the lens, the loss of which is the primary cause of the disorder. Leveraging existing knowledge about crosslinks and aggregates reduction, Lento has identified a lead candidate which significantly improves mouse lens stiffness when given in vivo as an eyedrop, and is currently in the lead optimization phase.
3. Nikhil Yadala, CEO of Healome One
AI based personalised coach to optimise health by measuring and slowing down aging, establishing causal relationships of habits on outcomes via easy-to-use D2C self experimentation mobile app and platform.
If you would like to pitch at an event, you can apply by filling out this short form: t.ly/6rpVX. All stages of projects are welcome. You must be a Longevity Global member to pitch. You can apply to join us here: https://longevitygl.org/join/.
Follow us on the platform formerly know as Twitter @LongevityGL